Clinical trial

Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories

NCT06167603

Study summary

ClinicalTrials.gov

Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention FDG-PET Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention Blood test and clinical examination. Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2023-04-30

PhaseN/A

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Interventions

FDG-PETDIAGNOSTIC_TEST

Blood test and clinical examination.DIAGNOSTIC_TEST

Sponsors & collaborators

IRCCS San Raffaelelead sponsor

IRCCS National Neurological Institute "C. Mondino" Foundationcollaborator

Mapped research locations

PaviaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06167603 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.